Curious about CAR T-cell therapy? We went straight to the source for answers. In this episode, the LLS Patient Education…
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers—but science is making real progress. In this episode,…
In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss…
A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options. In this episode,…
In this episode, we sit down with Dr. Bilal Abid from University of Texas Health Science Center in Houston to…
A stem cell transplant for blood cancer is just the beginning – what may come next for the patient can…
Research continues to accelerate for myelodysplastic syndromes (MDS), giving hope to patients and their loved ones. In this episode, Dr.…
Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin…
Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But…
Explore the cutting-edge of oncology as we delve into the revolutionary world of CAR T-cell therapy, a more recent medical…
In this episode, we speak with Dr. Matthew Matasar of Rutgers Cancer Institute, and Elizabeth Stone, who was diagnosed with…
In this episode, Dr. Sharon Castellino, a pediatric oncologist at Children’s Healthcare of Atlanta, examines the impact of healthcare equity…
Join us on a heartfelt journey woven by support and education, as we speak to Teresa Altemeyer, who was diagnosed…
Join us as we sit down with Dr. Deborah Stephens from the University of Utah, as we discover the latest…
Delve into the complex landscape of non-Hodgkin lymphoma research, where a cure is pursued amidst a backdrop of over 100…
While chronic myelomonocytic leukemia (CMML) is a rare disease, it is not rare to the patients and loved ones who…
Myeloproliferative Neoplasms (MPNS) is an umbrella term that includes myelofibrosis (MF), essential thrombocythemia (ET) and polycythemia vera (PV). In this…
Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial…
Join us as we speak to Dr. Richard Larson and Dr. Anand Patel from University of Chicago Medicine about chronic…
Join us as we speak to Laurie Adami, a follicular lymphoma (non-Hodgkin lymphoma) survivor. In this episode, Laurie shares her…
Join us as we speak to Dr. Anand Patel and Dr. Satyajit Kosuri from The University of Chicago Medicine about…
Please join us as we speak to Dr. Matthew Davids of Dana-Farber Cancer Institute. In this episode, Dr. Davids discusses…
Please join us as we speak to Dr. Shernan Holtan and guest co-host from LLS, Christina Neilsen. In this episode,…
Please join us as we speak to Dr. Daniel Pollyea from the University of Colorado School of Medicine. In this…
Join us as we speak with Charles Huang and Dr. Gabriel Mannis in honor of AML Awareness Day (April 21st).…
Join us as we speak to Dr. Hongtao Liu and Dr. Adam DuVall from University of Chicago Medicine, about current…
Join us as we speak to Dr. Peter Riedell and Dr. Benjamin Derman from University of Chicago Medicine, about the…
Join us as we speak to Dr. Brady Stein, a clinical hematologist and researcher at the Northwestern University Feinberg School…
Join us as we speak to Dr. Eunice Wang, the Chief of Leukemia Service and Professor of Oncology at Roswell…
Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a…
Join us as we speak to Dr. Grzegorz (Greg) Nowakowski, a physician researcher and Professor of Medicine at the Mayo…